Drug Trial Radar · NCT01443403
A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy
Last checked: Nov 20, 2026Latest source record: Jun 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
244
Actual
Start
Aug 17, 2011
Primary completion
Aug 22, 2012
Study completion Aug 22, 2012
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Sep 29, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine efficacy and safety of naldemedine for the treatment of opioid-induced constipation in adults with non-malignant chronic pain receiving opioid therapy for ≥ 3 months.
Conditions
- Opioid-induced Constipation
Interventions
PlaceboDrug
Matching placebo tablets administered orally once a day.
NaldemedineDrug
Naldemedine tablets administered orally once a day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Last 2 Weeks of the Treatment Period in the Number of Spontaneous Bowel Movements Per WeekTime frame: Baseline (2 weeks prior to randomization) and the last 2 weeks of treatment (Weeks 3 to 4 for participants who completed the 28-day treatment period)
Locations
49 sites in 1 country. Site status is shown where the registry gives one.
Shionogi Research Site
Phoenix, Arizona
Shionogi Research Site
Sun Lakes, Arizona
Shionogi Research Site
Little Rock, Arkansas
Shionogi Research Site
Anaheim, California
Shionogi Research Site
Fresno, California
Shionogi Research Site
Lincoln, California
Shionogi Research Site
Lomita, California
Shionogi Research Site
Denver, Colorado
Shionogi Research Site
Brandon, Florida
Shionogi Research Site
Kissimmee, Florida
Shionogi Research Site
New Port Richey, Florida
Shionogi Research Site
North Miami, Florida
Shionogi Research Site
Ocala, Florida
Shionogi Research Site
Orlando, Florida
Shionogi Research Site
Ormond Beach, Florida
Shionogi Research Site
Port Orange, Florida
Shionogi Research Site
Sarasota, Florida
Shionogi Research Site
South Miami, Florida
Shionogi Research Site
West Palm Beach, Florida
Shionogi Research Site
Atlanta, Georgia
Shionogi Research Site
Decatur, Georgia
Shionogi Research Site
Marietta, Georgia
Shionogi Research Site
Evansville, Indiana
Shionogi Research Site
Lexington, Kentucky
Shionogi Research Site
Shreveport, Louisiana
Shionogi Research Site
Owings Mills, Maryland
Shionogi Research Site
Watertown, Massachusetts
Shionogi Research Site
Worcester, Massachusetts
Shionogi Research Site
Traverse City, Michigan
Shionogi Research Site
Edina, Minnesota
Shionogi Research Site
Las Vegas, Nevada
Shionogi Research Site
Newington, New Hampshire
Shionogi Research Site
Berlin, New Jersey
Shionogi Research Site
Willingboro, New Jersey
Shionogi Research Site
Hartsdale, New York
Shionogi Research Site
North Syracuse, New York
Shionogi Research Site
Williamsville, New York
Shionogi Research Site
Wilmington, North Carolina
Shionogi Research Site
Winston-Salem, North Carolina
Shionogi Research Site
Canton, Ohio
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.